ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,680Medicare Part D Prescriptions Filled, Including Refills

Rank: 172 out of 1206

$386K Total Retail Price of All Prescriptions

Rank: 320 out of 1206

390 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 390 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 390 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 10,256 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 625 610 1 1
OMEPRAZOLE 401 387 2 3
LEVOTHYROXINE SODIUM 383 374 3 2
AMLODIPINE BESYLATE 348 348 4 6
FUROSEMIDE 306 294 5 5
LISINOPRIL 301 279 6 4
POTASSIUM CHLORIDE 269 268 7 12
HYDROCHLOROTHIAZIDE 262 255 8 11
WARFARIN SODIUM 254 242 9 8
SERTRALINE HCL 223 212 10 22
BENAZEPRIL HCL 220 210 11 39
ATENOLOL 200 200 12 14
ALENDRONATE SODIUM 187 181 13 19
HYDROCODONE-ACETAMINOPHEN 173 168 S3 14 7
METFORMIN HCL 166 166 15 10
METOPROLOL SUCCINATE 165 137 16 15
DIGOXIN 153 143 17 43
GEMFIBROZIL 152 150 18 71
METOPROLOL TARTRATE 151 136 19 9
TRAMADOL HCL 150 135 20 17
CARVEDILOL 147 137 21 32
ISOSORBIDE MONONITRATE ER 135 135 22 40
AMLODIPINE BESYLATE-BENAZEPRIL 120 120 23 76
CIPROFLOXACIN HCL 105 97 24 61
PREDNISONE 104 102 25 28
DONEPEZIL HCL 103 103 26 29
NAMENDA 100 100 27 36
ZOLPIDEM TARTRATE 98 79 28 25
DOXAZOSIN MESYLATE 94 94 29 75
ROPINIROLE HCL 79 79 30 77
LOSARTAN POTASSIUM 79 79 30 20
CRESTOR 74 51 32 30
MELOXICAM 74 74 32 35
ATORVASTATIN CALCIUM 64 64 34 13
AZITHROMYCIN 63 61 35 46
GABAPENTIN 62 62 36 18
BENAZEPRIL-HYDROCHLOROTHIAZIDE 62 62 36 133
MIRTAZAPINE 61 61 38 50
FENTANYL 60 51 S2 39 51
SPIRONOLACTONE 60 60 39 41
TAMSULOSIN HCL 59 58 41 26
FLUOXETINE HCL 57 53 42 52
OXYBUTYNIN CHLORIDE 57 48 42 68
CARBIDOPA-LEVODOPA 57 57 42 70
CLOPIDOGREL 57 57 42 48
PLAVIX 53 53 46 72
DILTIAZEM 24HR ER 52 52 47 174
BUSPIRONE HCL 51 51 48 110
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 9, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.